Research article: Monitoring the progression of metastatic breast cancer on nanoporous silica chips

Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences

Volumn 370, Issue 1967, 2012, Pages 2433-2447

  Fan, Jia ^a,b   Deng, Xiaoyong ^a,c   Gallagher, James W ^a   Huang, Haiyu ^a   Huang, Yi ^a   Wen, Jianguo ^a   Ferrari, Mauro ^a   Shen, Haifa ^a   Hu, Ye ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c SHANGHAI UNIVERSITY   (China)

Author keywords

Breast cancer lung metastasis; Early diagnosis; Low molecular weight protein; Nanoporous silica; Proteomic biomarker

Indexed keywords

BIOLOGICAL ORGANS; BIOMARKERS; BODY FLUIDS; CHEMOTHERAPY; DIAGNOSIS; MASS SPECTROMETRY; MOLECULAR WEIGHT; PATHOLOGY; PATIENT TREATMENT; PROTEINS; SILICA; TISSUE;

BREAST CANCER; CANCER DEVELOPMENT; EARLY DIAGNOSIS; EARLY-STAGE BREAST CANCER; EFFECTIVE THERAPY; HUMAN BREAST CANCER; LOW MOLECULAR WEIGHT; LUNG METASTASIS; MATRIX-ASSISTED LASER DESORPTION/IONIZATION-TIME-OF-FLIGHT MASS SPECTROMETRY; NANO-POROUS; NANOPOROUS SILICA; NUDE MICE; PERIODIC NANOSTRUCTURE; PERSONALIZED MEDICINES; PHYSIOLOGICAL STATE; PROTEIN SIGNATURES; PROTEINS/PEPTIDES; SERUM PROTEINS; SUCCESSFUL MANAGEMENT; TECHNICAL DIFFICULTIES;

DISEASES;

NANOPARTICLE; SILICON DIOXIDE; TUMOR MARKER;

ANIMAL; ARTICLE; BREAST TUMOR; DISEASE COURSE; FEMALE; HUMAN; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; METASTASIS; MOUSE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NANOPARTICLES; SILICON DIOXIDE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84860635448     PISSN: 1364503X     EISSN: None     Source Type: Journal    
DOI: 10.1098/rsta.2011.0444     Document Type: Article

References (28)

1. Jemal, A., Siegel, R., Xu, J. & Ward, E. 2010 Cancer statistics, 2010. CA: Cancer J. Clin. 60, 277-300. (doi:10.3322/caac.20073)
2. Pagani, O., Senkus, E., Wood, W., Colleoni, M., Cufer, T., Kyriakides, S., Costa, A., Winer, E. P. & Cardoso, F. 2010 International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J. Natl Cancer Inst. 102, 456-463. (doi:10.1093/jnci/djq029)
3. van den Hurk, C. J., Eckel, R., van de Poll-Franse, L. V., Coebergh, J. W., Nortier, J. W., Holzel, D., Breed, W. P. & Engel, J. 2011 Unfavourable pattern of metastases in M0 breast cancer patients during 1978-2008: a population-based analysis of the Munich Cancer Registry. Breast Cancer Res. Treat. 128, 795-805. (doi:10.1007/s10549-011-1372-y)
4. Mahner, S., Schirrmacher, S., Brenner, W., Jenicke, L., Habermann, C. R., Avril, N. & Dose-Schwarz, J. 2008 Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. Ann. Oncol. 19, 1249-1254. (doi:10.1093/annonc/mdn057) (Pubitemid 351911953)
5. Hodgson, N. C. & Gulenchyn, K. Y. 2008 Is there a role for positron emission tomography in breast cancer staging? J. Clin. Oncol. 26, 712-720. (doi:10.1200/JCO.2007. 13.8412) (Pubitemid 351264383)
6. Peto, R., Boreham, J., Clarke, M., Davies, C. & Beral, V. 2000 UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355, 1822. (doi:10.1016/S0140-6736(00)02277-7) (Pubitemid 30265099)
7. Chia, S. K. et al. 2007 The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110, 973-979. (doi:10.1002/cncr.22867) (Pubitemid 47312861)
8. Fidler, I. J. 2003 The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 3, 453-458. (doi:10.1038/nrc1098) (Pubitemid 37328849)
9. Krishnamurthy, S. et al. 2010 Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer 116, 3330-3337. (doi:10.1002/cncr.25145)
10. Riethdorf, S. & Pantel, K. 2010 Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann. N.Y. Acad. Sci. 1210, 66-77. (doi:10.1111/j.1749-6632.2010.05779.x)
11. Petricoin, E. F., Belluco, C., Araujo, R. P. & Liotta, L. A. 2006 The blood peptidome: a higher dimension of information content for cancer biomarker discovery. Nat. Rev. Cancer 6, 961-967. (doi:10.1038/nrc2011) (Pubitemid 44862680)
12. Liotta, L. A., Ferrari, M. & Petricoin, E. 2003 Clinical proteomics: written in blood. Nature 425, 905-905. (doi:10.1038/425905a) (Pubitemid 37376908)
13. Hanash, S. M., Pitteri, S. J. & Faca, V. M. 2008 Mining the plasma proteome for cancer biomarkers. Nature 452, 571-579. (doi:10.1038/nature06916) (Pubitemid 351483371)
14. Tirumalai, R. S., Chan, K. C., Prieto, D. A., Issaq, H. J., Conrads, T. P. & Veenstra, T. D. 2003 Characterization of the low molecular weight human serum proteome. Mol. Cell Proteomics 2, 1096-1103. (doi:10.1074/mcp.M300031- MCP200)
15. Domon, B. & Aebersold, R. 2006 Mass spectrometry and protein analysis. Science 312, 212-217. (doi:10.1126/science.1124619)
16. Gorg, A., Weiss, W. & Dunn, M. J. 2004 Current two-dimensional electrophoresis technology for proteomics. Proteomics 4, 3665-3685. (doi:10.1002/pmic.200401031) (Pubitemid 39657447)
17. Liu, H., Sadygov, R. G. & Yates III, J. R. 2004 A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201. (doi:10.1021/ac0498563) (Pubitemid 38943698)
18. Rabilloud, T. 2002 Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2, 3-10. (doi:10.1002/1615-9861(200201)2:1<3:AID-PROT3>3.0.CO;2-R) (Pubitemid 34273093)
19. Gao, D., Du, J., Cong, L. & Liu, Q. 2009 Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients. Jpn. J. Clin. Oncol. 39, 97-104. (doi:10.1093/jjco/hyn133)
20. Carey, L., Winer, E., Viale, G., Cameron, D. & Gianni, L. 2010 Triple-negative breast cancer: disease entity or title of convenience? Nat. Rev. Clin. Oncol. 7, 683-692. (doi:10.1038/nrclinonc.2010.154)
21. Bouamrani, A., Hu, Y., Tasciotti, E., Li, L., Chiappini, C., Liu, X. & Ferrari, M. 2010 Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome. Proteomics 10, 496-505. (doi:10.1002/pmic.200900346)
22. Hu, Y., Bouamrani, A., Tasciotti, E., Li, L., Liu, X. & Ferrari, M. 2010 Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano 4, 439-451. (doi:10.1021/nn901322d)
23. Hu, Y., Peng, Y., Lin, K., Shen, H., Brousseau III, L. C., Sakamoto, J., Sun, T. & Ferrari, M. 2011 Surface engineering on mesoporous silica chips for enriching low molecular weight phosphorylated proteins. Nanoscale 3, 421-428. (doi:10.1039/c0nr00720j)
24. Hu, Y., Gopal, A., Lin, K., Peng, Y., Tasciotti, E., Zhang, X. J. & Ferrari, M. 2011 Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip. Biomicrofluidics 5, 13410. (doi:10.1063/1.3528237)
25. Hu, Y., Peng, Y., Brousseau, L., Bouamrani, A., Liu, X. & Ferrari, M. 2010 Nanotexture optimization by oxygen plasma of mesoporous silica thin film for enrichment of low molecular weight peptides captured from human serum. Sci. China Chem. 53, 2257-2264. (doi:10.1007/s11426-010-4121-x)
26. Hu, Y., Fine, D. H., Tasciotti, E., Bouamrani, A. & Ferrari, M. 2011 Nanodevices in diagnostics. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3, 11-32. (doi:10.1002/wnan.82)
27. Feng, Y., Wen, J., Perez, M., Choi, D. S., Eshoa, C., Shi, Z. Z., Zu, Y. & Chang, C. C. 2010 Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells. Stem Cells Dev. 19, 1289-1296. (doi:10.1089/scd.2010.0010)
28. Hotelling, H. 1933 Analysis of a complex of statistical variables into principal components. J. Educ. Psychol. 24, 498-520. (doi:10.1037/h0070888)